Individualization:a new target of medical oncology in integration of modern medicine and traditional Chinese medicineSUN Yan1484-1488
Management system of phase Ⅳ clinical trialsLIU Lu, WEN Bao-shu, HUANG Qing-zhu, FENG Yi, ZHANG Pei-pei, LI Guo-qing1503-1507
Guideline on the need for carcinogenicity studies of pharmaceuticals in ChinaWANG Qing-li, WANG Hai-xue, HU Xiao-min, SUN Tao, ZHANG Ruo-ming, WANG Yu-zhu, YAN Li-ping, GUANG Hong-mei, PENG Jian, FENG Yi1508-1511
Progress in analysis of findings in the standard battery of genotoxicity testsZHOU Chang-hui, CHANG Yan, LIN Hai-xia, WANG Qing-li1512-1516
Transdermal absorption characteristics of brucine in vitro is affected by other alkaloids in total alkaloids from seed of Strychnos nux-vomicaLI Lei, CHEN Jun, CAI Bao-chang1517-1520
Progress and issues requiring attention in clinical application of targeted drugs for non-Hodgkin's lymphomasSHI Yuan-kai, XING Pu-yuan1521-1526
Advances in targeted treatments for advanced non-small-cell lung cancerWANG Yan, SUN Yan1527-1530,1546